Date: October 02, 2026
Board Meeting Outcomes
- Company received listing approvals from both BSE Limited and National Stock Exchange of India Limited for 12,50,000 equity shares allotted to promoters on preferential basis
- BSE approval reference: LOD/PREF/NJ/FIP/878/2026-27 dated October 01, 2026
- NSE approval reference: NSE/LIST/57597 dated October 01, 2026
Fundraising / Financing
- Equity Shares: 12,50,000 shares of face value ₹1 each
- Allottee: Promoters
- Issue Price: ₹600 per equity share (₹1 face value + ₹599 premium)
- Distinctive Numbers: 312456861 to 313706860
Regulatory Compliance Requirements
- Company must ensure compliance with Regulation 167 of SEBI (ICDR) Regulations
- Must file shareholding pattern in XBRL mode if change exceeds 2% of total paid-up share capital
- Trading approval requires:
- Listing approval from NSE (if applicable)
- Confirmation letters from NSDL/CDSL about crediting shares to beneficiary accounts
- Confirmation letters from NSDL/CDSL about lock-in of pre-preferential holding (if applicable)
- Must apply for trading approval within seven working days from date of grant of listing approval per SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023
Signatories and Correspondence
- Company Representative: Bharat Rajwani, Company Secretary & Compliance Officer
- BSE Signatories: Nitinkumar Pujari (Assistant Vice President), Tejas Tandel (Deputy Manager)
- NSE Signatory: Pooja Pashte (Manager)